Wave Life Sciences’ Post

View organization page for Wave Life Sciences, graphic

18,821 followers

We are excited to see more progress on the #NewbornScreening initiative for #Duchenne muscular dystrophy, this time in our home state of Massachusetts! MA is now the fourth state in the country to add Duchenne to their newborn screening panel. This will give more families the option of intervention and treatment earlier, with the potential to delay progression of the disease.

View organization page for CureDuchenne, graphic

5,646 followers

Exciting Progress in Newborn Screening for Duchenne! Massachusetts is taking a major step forward in infant health, and we're thrilled to see the state's commitment to expanding critical newborn screening for Duchenne muscular dystrophy. The state has 18 months to begin screening all newborns in the state for Duchenne.   This expansion is vital for early detection and intervention in Duchenne, providing families with timely access to crucial care and support. We're dedicated to advancing newborn screening initiatives across the country.    Our collaboration with Brigham and Women's Hospital in Boston has been instrumental in advocating for Duchenne to be included in the national Recommended Uniform Screening Panel (RUSP).   This is a significant step toward ensuring that every newborn in MA has access to treatments as early as possible. Read the full news release for more: https://lnkd.in/efjg_JRH #Duchenne #NewbornScreening #CureDuchenne #DMD #MaternalHealth

  • No alternative text description for this image
Alicia Suter

Senior Director, Corporate Communications at Wave Life Sciences

2mo

Great news!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics